Brief: Aeterna Zentaris Completes Enrollment In Ongoing Detect-Trial For Diagnosis Of Childhood-Onset Growth Hormone Deficiency

COSCIENS Biopharma

27/03/2024 12:53

March 27 (Reuters) - Aeterna Zentaris Inc  AEZS.TO :
    * AETERNA ZENTARIS REPORTS FOURTH QUARTER AND FULL YEAR 2023
FINANCIAL RESULTS AND ANNOUNCES COMPLETION OF ENROLLMENT IN
ONGOING PIVOTAL DETECT-TRIAL FOR THE DIAGNOSIS OF
CHILDHOOD-ONSET GROWTH HORMONE DEFICIENCY
    * AETERNA ZENTARIS INC - COMPANY ENDED YEAR WITH $34.0
MILLION IN
CASH, EXPECTED TO FUND OPERATIONS THROUGH 2024 AND INTO 2025

Source text for Eikon:  ID:nGNX3X776K 
Further company coverage:  AEZS.TO 

 ((Reuters.Briefs@thomsonreuters.com;))